Dr. Franck Borel obtained his PhD in 1992 at the EMBL Grenoble outstation. He worked in Reuben Leberman group on the recognition mechanisms of the tRNAs by their cognate aminoacyl RNA synthetase. After his thesis, he did a post-doctorate in the group of Paul Romaniuk at the University of Victoria (British Columbia, Canada). The research theme was the study of the attachment of zinc fingers to their target DNA. Following his stay in Canada, he moved, as a post-doctoral fellow, to the team of Robert Margolis at the “Institut de Biologie Structurale” in Grenoble where he was involved in cell biology projects related to tetraploidy checkpoint control. In 2001, he joined the structural genomics team and the IBS Synchrotron group (GSY) led by Jean-Luc Ferrer. He began to work on structural biology projects such as drosophilia nuclear receptors or enzymes of the plants phenylpropanoid pathway. He was also involved on the beamline BM30A-FIP, either for the improvement of the beamline or for helping users. (GSY designed and manages PX beamline FIP-BM30A at the European Synchrotron Radiation Facility and is developing its own research projects in structural biology. In the context of the ESRF-EBS upgrade, FIP is being rebuilt as “FIP2-B07” and will be operational at the end of 2020). In 2004, he became a research associate and in 2008 he was recruited by the “Commissariat à l´énergie atomique et aux énergies alternatives” (CEA) in Jean-Luc Ferrer group. Since then, he has continued his involvement on the beamline and has started to work on several enzymes of the MEP pathway.
The official website of the Mepanti project